
Tenet Healthcare (THC) Stock Forecast & Price Target
Tenet Healthcare (THC) Analyst Ratings
Bulls say
Tenet Healthcare is positioned for strong growth due to its strategic investment in the USPI segment, which offers higher margins and returns, contributing to improved return on invested capital (ROIC). The company's focus on outpatient growth opportunities, alongside a favorable payer mix and lower labor costs, suggests significant potential for enterprise-wide margin expansion. Additionally, an anticipated rise in income from equity earnings in 2026, bolstered by favorable volume trends and state supplemental payments, reinforces a positive outlook for Tenet Healthcare.
Bears say
Tenet Healthcare's stock outlook is negatively impacted by significant potential headwinds associated with the expiration of subsidies, with an estimated $220 million adverse effect on its Acute segment and another $30 million on its USPI segment for 2026 forecasts. Additionally, the company faces challenges from a projected 20% decline in Health Insurance Exchange coverage, which could result in 80-85% of these individuals becoming uninsured, further decreasing patient utilization. Though Tenet recorded a one-time gain of $148 million from Medicaid state funds in 2025, the reliance on such non-recurring revenue raises concerns about the sustainability of its financial performance moving forward.
This aggregate rating is based on analysts' research of Tenet Healthcare and is not a guaranteed prediction by Public.com or investment advice.
Tenet Healthcare (THC) Analyst Forecast & Price Prediction
Start investing in Tenet Healthcare (THC)
Order type
Buy in
Order amount
Est. shares
0 shares